Larson and Gill [226] demonstrated that FGF21 signalling was dysregulated in both AD and cardiometabolic disorders such as T2D, suggesting that FGF21 could be a possible link between AD and T2D. The gene discussed is FGF21; the disease is type 2 diabetes mellitus.